PMC7383648_01
CT reveals intramural gastric gas spread throughout the stomach (black arrows), coexisting with IFG around the stomach (white arrows), but not ascites (a). HPVG is identified, especially in the left lobe of the liver (white arrows) (b).
10.1177_2050313X20945946-fig1.jpg
PMC7383648_01_10.1177_2050313X20945946-fig1.jpg
fig1-2050313X20945946
Moreover, HPVG, especially in the left lobe of the liver, was also identified, coexisting with IFG around the stomach, but ascites was not present (Figure 1(a) and (b)).
Upper gastrointestinal series by oral water-soluble contrast medium reveals no perforations in the stomach.
10.1177_2050313X20945946-fig2.jpg
PMC7383648_01_10.1177_2050313X20945946-fig2.jpg
fig2-2050313X20945946
We initially assumed perforation of the digestive tract; however, the upper gastrointestinal series using oral water-soluble contrast medium revealed no perforating site in the stomach (Figure 2).
CT reveals intramural gastric gas, IFG, and HPVG disappearing 3 days after the treatment.
10.1177_2050313X20945946-fig3.jpg
PMC7383648_01_10.1177_2050313X20945946-fig3.jpg
fig3-2050313X20945946
In addition, the follow-up CT revealed that the intramural gastric gas, IFG, and HPVG disappeared just 3 days after the treatment (Figure 3).
Esophagogastroduodenoscopy shows only mild redness in the upper stomach.
10.1177_2050313X20945946-fig4.jpg
PMC7383648_01_10.1177_2050313X20945946-fig4.jpg
fig4-2050313X20945946
After the patient was completely relieved of the symptoms, esophagogastroduodenoscopy showed mild redness in the upper stomach on the 10th day (Figure 4), and total colonoscopy showed no abnormalities on the 17th day after starting the treatment.